CELLULAR IMMUNOLOGY
Scope & Guideline
Connecting Scholars in Cellular Immunology
Introduction
Aims and Scopes
- Immune Cell Functionality:
Research on the roles and mechanisms of various immune cells, including T cells, B cells, macrophages, and dendritic cells, in health and disease. - Signaling Pathways in Immunology:
Studies investigating the intracellular signaling pathways that regulate immune responses, such as NF-κB, MAPK, and JAK-STAT pathways. - Inflammation and Autoimmunity:
Exploration of the mechanisms and pathways involved in inflammatory responses and autoimmune diseases, providing insights into potential therapeutic targets. - Cancer Immunology:
Research focused on the interactions between the immune system and tumors, including immune evasion mechanisms and the development of immunotherapies. - Regulatory Mechanisms in Immunity:
Investigations into the regulatory networks that govern immune cell differentiation, activation, and function, including the role of regulatory T cells and cytokines. - Infectious Disease Immunology:
Studies examining immune responses to various pathogens, including bacteria, viruses, and parasites, and the implications for vaccine development and treatment. - Microbiome and Immunity:
Research exploring the relationship between the microbiome and the immune system, including how gut microbiota influences immune responses.
Trending and Emerging
- Cancer Immunotherapy:
An increasing focus on novel immunotherapeutic strategies, including CAR-T cell therapy, checkpoint inhibitors, and the role of the tumor microenvironment in shaping immune responses. - Regulatory T Cell Mechanisms:
Heightened interest in understanding the roles of regulatory T cells and their mechanisms in maintaining immune homeostasis and preventing autoimmune diseases. - Innate Immunity and Inflammation:
Growing research on the innate immune system's role in inflammation, particularly concerning diseases like COVID-19 and autoimmune conditions. - Microbiome and Immune Interactions:
Emerging studies investigating the intricate relationships between the microbiome and immune responses, emphasizing the microbiome's impact on health and disease. - Novel Biomarkers and Therapeutic Targets:
Increased emphasis on identifying biomarkers for immune responses and potential therapeutic targets, especially in cancer and autoimmune diseases. - Metabolic Regulation of Immune Cells:
Research exploring how metabolic processes influence immune cell function and differentiation, providing insights into new therapeutic strategies.
Declining or Waning
- Traditional Vaccine Development:
Research focusing solely on conventional vaccine development has diminished, with a shift towards novel approaches such as mRNA vaccines and dendritic cell vaccines. - Basic Immunological Mechanisms:
General studies on fundamental immunological processes without specific applications or disease contexts are less frequently published, as the field moves towards more translational and applied research. - Autoimmunity without Therapeutic Context:
Papers exploring autoimmunity without linking findings to therapeutic implications or translational research have become less common, indicating a preference for studies with direct clinical relevance. - Single Cell Analysis in Non-Cancer Contexts:
While single-cell analysis remains a hot topic, studies focusing on non-cancer contexts have decreased, as the applications in cancer immunology have gained more traction.
Similar Journals
INTERNATIONAL IMMUNOLOGY
Pioneering Research at the Intersection of Immunology and Medicine.INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.
VIRAL IMMUNOLOGY
Transforming understanding of viruses and host immunity.Viral Immunology, published by Mary Ann Liebert, Inc, stands as a prominent journal dedicated to advancing the understanding of the interplay between viral infections and host immune responses. With a strong focus on immunology, molecular medicine, and virology, the journal provides a platform for the dissemination of high-quality research findings and innovative methodologies that could shape the future of these critical fields. Although it currently holds a Q3 rating across its relevant categories and a respectable ranking within the Scopus database, Viral Immunology continues to strive for excellence with a commitment to publishing influential research that informs both academic and clinical practices. The journal accepts submissions in various formats—original research, reviews, and commentaries—catering to a diverse readership that includes researchers, professionals, and students engaged in the biological and medical sciences. Readers can anticipate insightful articles that address urgent challenges in immunological responses to viral infections, paving the way for new therapeutic strategies and public health initiatives.
Annual Review of Immunology
Unraveling the Complexities of ImmunityThe Annual Review of Immunology, published by Annual Reviews, is a premier journal that has been contributing to the field of immunology since its establishment in 1983. With a strong reputation highlighted by its impressive impact factor and top-tier rankings—holding the Q1 category in both Immunology and Immunology and Allergy, alongside significant Scopus Rankings—this journal serves as an essential resource for researchers, professionals, and students alike. The Annual Review of Immunology covers the latest advancements and critical developments in the domain, fostering a better understanding of immune responses and disorders. Although it is not an open-access journal, it provides comprehensive reviews that synthesize emerging data and trends, making it indispensable for those at the forefront of immunological research. With volumes anticipated through 2024, it continues to set the standard for high-quality scholarly publications in the field.
IMMUNOBIOLOGY
Advancing the frontiers of immunology and hematology.IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.
EUROPEAN JOURNAL OF IMMUNOLOGY
Advancing Immunology Through Pioneering ResearchWelcome to the European Journal of Immunology, a premier peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Established in 1971 and published by Wiley, this esteemed journal has been consistently ranked in the top quartile (Q1) across its categories, highlighting its significant impact within the scientific community. With an impressive Scopus ranking, the journal occupies the 64th position in Immunology and Allergy and the 74th in the broader sector of Immunology and Microbiology, demonstrating its vital role in driving innovation and knowledge in immunological studies. The European Journal of Immunology publishes high-quality original research, comprehensive reviews, and insightful commentary, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to understanding the complexities of the immune system. Although not an open-access journal, it offers various subscription options to ensure that institutions and individuals can access pivotal research that shapes the future of immunology.
INFLAMMATION RESEARCH
Advancing knowledge in the realm of inflammation.INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.
MOLECULAR IMMUNOLOGY
Decoding the Molecular Language of the Immune SystemMOLECULAR IMMUNOLOGY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, is a highly regarded journal in the fields of Immunology and Molecular Biology. With a focus on advancing the understanding of the immune system at the molecular level, the journal has been a critical resource since its inception in 1975. The journal is currently listed in the second quartile (Q2) of its category as per the 2023 rankings, indicating its substantial impact in both Immunology and Molecular Biology research. Researchers and professionals benefit from the journal's rigorous peer-review process and its commitment to publishing high-quality original research, reviews, and methodological studies that explore the intricate dynamics of immune responses. Although it does not currently offer an open access option, MOLECULAR IMMUNOLOGY remains an essential platform for scholars, emphasizing the significance of molecular interactions within the immune system and their implications in health and disease.
FEBS Journal
Catalyzing Progress in Biochemistry and BeyondFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
BMC IMMUNOLOGY
Transforming Immunology Through Open AccessBMC Immunology is a prominent open-access journal published by BMC that has been at the forefront of immunological research since its inception in 2000. Based in the United Kingdom, this journal aims to advance the understanding of immune system functions and disorders through high-quality, peer-reviewed articles. With an impressive scope encompassing various facets of immunology, BMC Immunology has earned a Q3 ranking in the Immunology category according to the 2023 category quartiles, demonstrating its growing impact and relevance in the scientific community. Researchers and professionals will find valuable insights in its array of published works, spanning both foundational studies and innovative applications. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and advancement in the field. For those looking to stay updated on the latest developments in immunology, BMC Immunology stands as an essential resource for researchers, professionals, and students alike.
Immunity Inflammation and Disease
Elevating the discourse on therapeutic strategies for inflammatory diseases.Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.